WNT signaling in tumors: the way to evade drugs and immunity
E Martin-Orozco, A Sanchez-Fernandez… - Frontiers in …, 2019 - frontiersin.org
WNT/β-catenin signaling is involved in many physiological processes. Its implication in
embryonic development, cell migration, and polarization has been shown. Nevertheless …
embryonic development, cell migration, and polarization has been shown. Nevertheless …
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
There has been a surge of interest in recent years in understanding the intricate
mechanisms underlying cancer progression and treatment resistance. One molecule that …
mechanisms underlying cancer progression and treatment resistance. One molecule that …
Detection approaches for multidrug resistance genes of leukemia
Y Du, B Chen - Drug Design, Development and Therapy, 2017 - Taylor & Francis
Leukemia is a clonal malignant hematopoietic stem cell disease. It is the sixth most lethal
cancer and accounts for 4% of all cancers. The main form of treatment for leukemia is …
cancer and accounts for 4% of all cancers. The main form of treatment for leukemia is …
Metabolic reprogramming during multidrug resistance in leukemias
RS Vidal, J Quarti, MF Rodrigues, FD Rumjanek… - Frontiers in …, 2018 - frontiersin.org
Cancer outcome has improved since introduction of target therapy. However, treatment
success is still impaired by the same drug resistance mechanism of classical chemotherapy …
success is still impaired by the same drug resistance mechanism of classical chemotherapy …
Attenuated JNK signaling in multidrug-resistant leukemic cells. Dual role of MAPK in cell survival
D Cerezo, AJ Ruiz-Alcaraz, M Lencina-Guardiola… - Cellular …, 2017 - Elsevier
Having found previously that leukemic cells with multidrug resistant (MDR) phenotype, but
not their sensitive counterparts, exhibit collateral sensitivity to cold stress in a P-gp …
not their sensitive counterparts, exhibit collateral sensitivity to cold stress in a P-gp …
Collateral sensitivity in drug-resistant tumor cells
M Saeed, HJ Greten, T Efferth - … Mechanisms of Tumor Cell Resistance to …, 2013 - Springer
Collateral sensitivity is a term for the hypersensitivity of otherwise drug-resistant cells. The
selective killing of tumor cells by drugs exerting collateral sensitivity might be used as a …
selective killing of tumor cells by drugs exerting collateral sensitivity might be used as a …
Collateral sensitivity to cold stress and differential BCL-2 family expression in new daunomycin-resistant lymphoblastoid cell lines
D Cerezo, M Cánovas, P García-Peñarrubia… - Experimental Cell …, 2015 - Elsevier
The acquisition of a multidrug-resistant (MDR) phenotype by tumor cells is one of the main
causes of chemotherapy failure in cancer, and, usually, is due to the increased expression of …
causes of chemotherapy failure in cancer, and, usually, is due to the increased expression of …
ABC-transporters and drug efflux in hematologic cancers
A Lazarowski - Drug Efflux Pumps in Cancer Resistance Pathways …, 2020 - Elsevier
Multi-drug resistance (MDR) is a common phenomenon produced in cancer by the loss of
therapeutic response in spite of the wide spectrum of drugs prescribed. Hematologic …
therapeutic response in spite of the wide spectrum of drugs prescribed. Hematologic …
Therapeutic Applications of Bioconjugates in Human Disease
P McKernan - 2018 - shareok.org
The unifying element tying together the therapeutics presented in this thesis is annexin A5.
The protein, annexin 5 (ANXA5), is a membrane management protein that specifically binds …
The protein, annexin 5 (ANXA5), is a membrane management protein that specifically binds …